Alignment among public formularies in Canada, part 3 : medicines assessed by the common drug review.: H82-29/3-2022E-PDF

"This is the last report in a three-part PMPRB series that explores current overlaps and gaps in Canadian public drug plan formularies"--Executive summary, page ii.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.907333&sl=0

Publication information
Department/Agency Canada. Patented Medicine Prices Review Board, issuing body.
Title Alignment among public formularies in Canada, part 3 : medicines assessed by the common drug review.
Publication type Monograph
Language [English]
Other language editions [French]
Format Electronic
Electronic document
Note(s) Issued also in French under title: Concordance des listes de médicaments des régimes publics au Canada, partie 3 : médicaments évalués par le programme commun d'évaluation des médicaments.
Issued also in HTML format.
Includes bibliographical references.
Publishing information Ottawa, ON : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, February 2022.
©2022
Description 1 online resource (iii, 21 pages) : colour charts
ISBN 9780660417950
Catalogue number
  • H82-29/3-2022E-PDF
Subject terms Pharmaceutical services insurance -- Canada -- Statistics.
Drugs -- Canada -- Statistics.
Pharmaceutical policy -- Canada.
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.
Report a problem or mistake on this page
Date modified: